Everolimus

3:09
Analysis of OS based on early tumor shrinkage in the phase III METEOR study
Ignacio Duran
1:31
Achieving better response rates in metastatic RCC
Bradley McGregor
2:16
The agents at the forefront of kidney cancer treatment
Michael Atkins
2:31
Changing the standard of care in previously treated metastatic renal cell carcinoma
Laurence Albiges
3:52
CheckMate 025: Phase 3 trial of nivolumab for advanced kidney cancer
Padmanee Sharma
1:03
AZD2014 for treating ER+ metastatic breast cancer – mode of action and trial results
Erika Hamilton
1:12
Cabozantinib for advanced renal cell carcinoma: the METEOR and CABOSUN trials
Sumanta Pal
1:40
Phase III METEOR trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
Toni Choueiri
4:12
CABOSUN trial of cabozantinib – could it change how we treat frontline RCC?
Toni Choueiri
1:11
Results of trial of ribociclib with everolimus and exemestane in breast cancer
Mafalda Olivera
5:57
Current landscape and future direction in systemic therapy for renal cell carcinoma (RCC)
Susanne Osanto
VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJOncology is intended for healthcare professionals